COGT — Cogent Biosciences, Inc. stock price, charts and financials

QT59Cogent Biosciences, Inc.

Cogent Biosciences, Inc. (NASDAQ: COGT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.50
-1.69-5.09%
OverviewShort InterestFilings
COGTQT59Cogent Biosciences, Inc.·NASDAQ
31.50-5.09%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 02, 20268-KCurrent report
Aug 31, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026424B5Prospectus
Aug 10, 20268-KCurrent report
Aug 10, 20268-KCurrent report
Aug 10, 202610-QQuarterly report
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
May 21, 20264Statement of changes in beneficial ownership
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Apr 03, 20264Statement of changes in beneficial ownership
#1 / 25 of 319
Page
▼
/ 13